1. Home
  2. VERU vs GGR Comparison

VERU vs GGR Comparison

Compare VERU & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • GGR
  • Stock Information
  • Founded
  • VERU 1971
  • GGR 2011
  • Country
  • VERU United States
  • GGR Taiwan
  • Employees
  • VERU N/A
  • GGR N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • GGR Auto Manufacturing
  • Sector
  • VERU Health Care
  • GGR Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • GGR Nasdaq
  • Market Cap
  • VERU 85.5M
  • GGR 80.6M
  • IPO Year
  • VERU 1990
  • GGR N/A
  • Fundamental
  • Price
  • VERU $0.49
  • GGR $0.38
  • Analyst Decision
  • VERU Strong Buy
  • GGR Hold
  • Analyst Count
  • VERU 2
  • GGR 2
  • Target Price
  • VERU $4.00
  • GGR $0.50
  • AVG Volume (30 Days)
  • VERU 1.4M
  • GGR 584.8K
  • Earning Date
  • VERU 08-07-2025
  • GGR 08-12-2025
  • Dividend Yield
  • VERU N/A
  • GGR N/A
  • EPS Growth
  • VERU N/A
  • GGR N/A
  • EPS
  • VERU N/A
  • GGR N/A
  • Revenue
  • VERU $16,886,419.00
  • GGR $304,551,000.00
  • Revenue This Year
  • VERU N/A
  • GGR N/A
  • Revenue Next Year
  • VERU N/A
  • GGR $5.00
  • P/E Ratio
  • VERU N/A
  • GGR N/A
  • Revenue Growth
  • VERU 134.43
  • GGR N/A
  • 52 Week Low
  • VERU $0.45
  • GGR $0.19
  • 52 Week High
  • VERU $1.42
  • GGR $1.56
  • Technical
  • Relative Strength Index (RSI)
  • VERU 35.42
  • GGR 61.23
  • Support Level
  • VERU $0.49
  • GGR $0.38
  • Resistance Level
  • VERU $0.61
  • GGR $0.40
  • Average True Range (ATR)
  • VERU 0.04
  • GGR 0.02
  • MACD
  • VERU -0.01
  • GGR -0.00
  • Stochastic Oscillator
  • VERU 2.27
  • GGR 78.11

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

Share on Social Networks: